Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital
Udgivet

Annexin A2 and cancer: A systematic review

Publikation: Bidrag til tidsskriftReviewForskningpeer review

DOI

  1. The collagen receptor uPARAP/Endo180 in tissue degradation and cancer (Review)

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Prevalence of chromosomal rearrangements involving non-ETS genes in prostate cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Carboplatin treatment of antiestrogen-resistant breast cancer cells

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Preoperative predictors of inguinal lymph node metastases in vulvar cancer - A nationwide study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Defining Substantial Lymphovascular Space Invasion in Endometrial Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  3. Substantial Lymphovascular Space Invasion Is an Adverse Prognostic Factor in High-risk Endometrial Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Identification of Stably Expressed Reference microRNAs in Epithelial Ovarian Cancer

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  5. CA-125 Levels Are Predictive of Survival in Low-Grade Serous Ovarian Cancer-A Multicenter Analysis

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

Annexin A2 is a 36-kDa protein interfering with multiple cellular processes especially in cancer progression. The present review aimed to show the relations between Annexin A2 and cancer. A systematic search for studies investigating cancer and Annexin A2 expression was conducted using PubMed. Acute lymphoblastic leukaemia, acute promyelocytic leukaemia, clear cell renal cell carcinoma, breast, cervical, colorectal, endometrial, gastric cancer, glioblastoma, hepatocellular carcinoma, lung, multiple myeloma, oesophageal squamous cell carcinoma, ovarian cancer, pancreatic duct adenocarcinoma, prostate cancer and urothelial carcinoma were evaluated. Annexin A2 expression correlates with resistance to treatment, binding to the bone marrow, histological grade and type, TNM-stage and shortened overall survival. The regulation of Annexin A2 is of interest due to its potential as target for a more individualized cancer management.

OriginalsprogEngelsk
TidsskriftInternational Journal of Oncology
Vol/bind52
Udgave nummer1
Sider (fra-til)5-18
Antal sider14
ISSN1019-6439
DOI
StatusUdgivet - jan. 2018

ID: 55853661